Christobel Selecky
Director · ImmunityBio, Inc.
- 2026
- Jul 7, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christobel Selecky files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Barry J. Simon - $4.41M in IBRX purchases and sales in the last 12 months
- Cheryl Cohen - $2.10M in IBRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christobel Selecky?
Christobel Selecky is a corporate insider, tracked as Director of ImmunityBio, Inc. (IBRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Christobel Selecky last file a Form 4?
The most recent primary Form 4 on record is dated 7 July 2026, one of 5 filings going back to 2026.
Has Christobel Selecky been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($3.00M) across all tracked filings.
